Emerging potential benefits of modulating NAD<sup>+</sup>metabolism in cardiovascular disease
Daniel S. Matasic(University of Iowa), Barry London(University of Pittsburgh)
American Journal of Physiology-Heart and Circulatory Physiology
December 25, 2017
Cited by 64
Related Papers
Meta-Analysis of Trials on Prophylactic Use of Levosimendan in Patients Undergoing Cardiac Surgery
|The Annals of Thoracic Surgery|2018|24
Outcomes of Surgical Ablation in Patients With Atrial Fibrillation Undergoing Cardiac Surgeries
|The Annals of Thoracic Surgery|2018|5